A 24-week prospective open-label multicenter study to evaluate the effect on seizure frequency, safety and tolerability of oxcarbazepine monotherapy in children with partial seizures
Phase of Trial: Phase IV
Latest Information Update: 01 Mar 2017
At a glance
- Drugs Oxcarbazepine (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- Sponsors Novartis
- 05 Dec 2007 Status changed from in progress to completed.
- 07 Aug 2007 Status changed from recruiting to in progress.
- 27 Jul 2006 New trial record.